UNIVERCELLS Revenue and Competitors
Estimated Revenue & Valuation
- UNIVERCELLS's estimated annual revenue is currently $28.7M per year.
- UNIVERCELLS's estimated revenue per employee is $155,000
Employee Data
- UNIVERCELLS has 185 Employees.
- UNIVERCELLS grew their employee count by 5% last year.
UNIVERCELLS's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Human Resources Officer | Reveal Email/Phone |
2 | Project Definition Manager | Reveal Email/Phone |
UNIVERCELLS Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 32 | -26% | N/A | N/A |
#2 | $510.1M | 1097 | 31% | $2B | N/A |
#3 | $13.6M | 88 | 44% | N/A | N/A |
#4 | $12.2M | 79 | 0% | N/A | N/A |
#5 | $28.7M | 185 | 5% | N/A | N/A |
#6 | $35.2M | 227 | 8% | N/A | N/A |
#7 | $4M | 26 | -10% | N/A | N/A |
#8 | $10.9M | 70 | 23% | N/A | N/A |
#9 | $10.4M | 67 | 24% | N/A | N/A |
#10 | $6.2M | 40 | 29% | N/A | N/A |
What Is UNIVERCELLS?
Univercells is a business-to-business provider focused on increasing the availability of affordable vaccines and biotherapeutics to address global health challenges. The company is developing turnkey solution for a series of vaccines and biotherapeutics to be delivered at an affordable price. By relying on proprietary core technologies and a continuous process intensification approach, production is achieved with a smaller footprint, and significantly lower overall capital and operational costs. Univercells was founded in 2013 by experienced entrepreneurs Hugues Bultot, CEO, and José Castillo, CTO, who bring close to 25 years of expertise in the biotechnology and life sciences sectors. Headquartered in Gosselies (Belgium), Univercells benefits from support from the Walloon region, and received €3 million as early seeding from Takeda in 2015. At the end of 2016, the company was awarded a $16 million grant from the Bill & Melinda Gates Foundation.
keywords:N/A
N/A
Total Funding
185
Number of Employees
$28.7M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
UNIVERCELLS News
Combining our process know-how with Univercells Technologies' Nevoline will provide Low- and Middle-Income countries with access to much...
Scale-up development will use Univercells Technologies NevoLine Upstream platform, which provides automated large-scale virus manufacturing...
As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide custom-...
Univercells — a bioprocessing provider focused on increasing the availability of affordable biologics to address global health challenges — announced it is raising up to €50 million financings from Gamma Biosciences Univercells — a bioprocessing provider focused on increasing the availability o ...
Univercells, a Gosselies, Belgium-based a technology company offering novel biomanufacturing platforms, aimed at increasing the availability and affordability of biologics – recombinant proteins and vaccines, closed a €16m ($18.8m) Series B equity financing. The financing came from Global Healt ...
Other Companies in Gosselies
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $36.8M | 190 | 42% | $249.7M |